Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2423 in posttraumatic neuralgia
NCT01200524Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of azd2423 in post-traumatic neuralgia, sponsored by AstraZeneca. Started Oct 2010; status: completed.
02
Drugs
azd2423
03
Conditions
post-traumatic neuralgia
Beyond the preview
Go deeper on NCT01200524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200524.